Brain cancer breakthrough? trial adds radiation during surgery to fight glioblastoma
NCT ID NCT02685605
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether giving a dose of radiation directly to the tumor site during surgery (intraoperative radiotherapy) can help people with a newly diagnosed aggressive brain cancer called glioblastoma live longer without their cancer growing. The study involves 314 adults aged 18 to 80 who are healthy enough for surgery. The goal is to see if adding this extra radiation to the usual treatment plan improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barrow Neurological Institute (SJHMC)
Phoenix, Arizona, 85013, United States
-
Beijing Tian Tan Hospital, Capital Medical University
Beijing, 100050, China
-
Catalan Institute of Oncology (ICO)
Barcelona, 08908, Spain
-
Charité - Universitätsmedizin
Berlin, 13353, Germany
-
Gangnam Severance Hospital, Yonsei University College of Medicine
Seoul, 06273, South Korea
-
Helios University Hospital Wuppertal
Wuppertal, 42283, Germany
-
Hospital Alemão Oswaldo Cruz
São Paulo, 01323-020, Brazil
-
Hospital Reina Sofia
Córdoba, Spain
-
Klinikum Stuttgart
Stuttgart, 70174, Germany
-
Lenox Hill Hospital, Hofstra Northwell School of Medicine
New York, New York, 10028, United States
-
Long Island Jewish Medical Center, North Shore University Hospital
Lake Success, New York, 11042, United States
-
Montreal Neurological Institute and Hospital
Montreal, Quebec, H3A 2B4, Canada
-
St. Georg Hospital
Leipzig, Germany
-
Stritch School of Medicine Loyola University
Maywood, Illinois, 60153, United States
-
Technical University of Munich (TUM), Department of Radiation Oncology
Munich, 81675, Germany
-
The London Clinic
London, W1G 6BW, United Kingdom
-
University Hospital Augsburg
Augsburg, 86156, Germany
-
University Hospital Mannheim
Mannheim, 68167, Germany
-
West Virginia University
Morgantown, West Virginia, 26506-9260, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging clues could sharpen brain tumor monitoring
- Can a virus injected into brain tumors fight recurrence?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a seizure drug outsmart a deadly brain tumor?
- A simple lotion duo may shield skin from Tumor-Treating fields
- Can a One-Two punch slow recurrent brain cancer?